Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Office Properties Income Trust Q3 2026: Net Loss and Bankruptcy Emergence

Office Properties Income Trust filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 9, 2026, covering results both before and after the company's emergence from Chapter 11 bankruptcy proceedings.

Anjali Anand | 09 November 2026

JBS N.V. Issues Q3 2026 Earnings Release via 8-K

JBS N.V. filed a Form 8-K with the SEC on November 9, 2026, disclosing that it issued an earnings release covering results for the quarter ended September 30, 2026.

Manish Choudhary | 09 November 2026

JBS Agrees to Acquire Flora and Canal Rural From J&F

JBS N.V. filed a Form 8-K on November 9, 2026, disclosing that its wholly owned Brazilian subsidiary JBS S.A. entered into two share purchase agreements to acquire Flora Produtos de Higiene e Limpeza S.A. and Canal Rural Produções Ltda. from related party J&F S.A.

Anjali Anand | 09 November 2026

InfuSystem Q3 2026: Net Income Rises to $3.16M

InfuSystem Holdings, Inc. filed its Form 10-Q with the SEC on November 9, 2026, reporting unaudited financial results for the quarterly period ended September 30, 2026, listed on NYSE American under the ticker INFU.

Aditi Sarkar | 09 November 2026

Bain Capital Specialty Finance Q3 2026: NAV Falls to $16.49

Bain Capital Specialty Finance, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 9, 2026, reporting a decline in net asset value per share and total net assets compared to year-end 2025.

Nitish Kishor | 09 November 2026

Puma Biotechnology Q3 2026: Net Product Revenue $54.1M

Puma Biotechnology, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting third-quarter net product revenue of $54.1 million and nine-month income from operations of $9.031 million.

Nitish Kishor | 09 November 2026

Bain Capital Specialty Finance Appoints Amrit Kanwal to Board

Bain Capital Specialty Finance, Inc. filed a Current Report on Form 8-K on November 9, 2026, disclosing the appointment of Amrit Kanwal as an independent Class III director, a bylaw amendment expanding the board from eight to nine members, Q3 2026 financial results, and …

Nitish Kishor | 09 November 2026

Amrit Kanwal Files Initial Ownership Report at Bain Capital Specialty Finance

Director Amrit Kanwal filed a Form 3 initial statement of beneficial ownership with the SEC on November 9, 2026, disclosing holdings in Bain Capital Specialty Finance, Inc. as of a triggering event dated November 4, 2026.

Manish Choudhary | 09 November 2026

Baldwin Insurance Group Q3 2026: 98.3M Shares, Go-Private Plan

The Baldwin Insurance Group, Inc. filed its quarterly report on Form 10-Q with the SEC for the period ended September 30, 2026, disclosing financial results, capital structure details, and an ongoing go-private transaction that would delist its Class A common stock from Nasdaq.

Aakashdeep | 09 November 2026

Perspective Therapeutics Q3 2026 Results Filed November 9

Perspective Therapeutics, Inc. filed a current report on Form 8-K on November 9, 2026, disclosing its financial results for the quarter ended September 30, 2026, along with an updated corporate presentation posted the same day.

Aditi Sarkar | 09 November 2026
Support

Hi! How can we help you today?

Loading…